|
Last Updated: Nov 17th, 2006 - 22:35:04 |
Latest Research
:
Psychiatry
:
Substance Abuse
:
Cannabis
Increase in psychotic symptoms predicts relapse to cannabis use
There may be a two-way relationship between cannabis use and psychosis, according to a new study from Australia. Published in the August issue of the British Journal of Psychiatry, the study found that more frequent cannabis use was associated with a higher risk of psychotic relapse, and more severe psychotic symptoms were associated with increased risk of cannabis relapse.
Aug 9, 2006, 12:41
Latest Research
:
Psychiatry
:
Substance Abuse
:
Cannabis
New PET Radiotracer to Visualize Cannabinoid Receptors Developed
A team of Johns Hopkins researchers developed a new radiotracer�a radioactive substance that can be traced in the body�to visualize and quantify the brain�s cannabinoid receptors by positron emission tomography (PET), opening a door to the development of new medications to treat drug dependence, obesity, depression, schizophrenia, Parkinson�s disease and Tourette syndrome.
Jun 6, 2006, 23:56
Latest Research
:
Psychiatry
:
Substance Abuse
:
Cannabis
Cannabis Based Medicine to be Supplied in Spain
GW Pharmaceuticals is today pleased to announce that it has reached agreement with the Health Department of The Regional Government of Catalonia in Spain to supply Sativex � oromucosal spray, its cannabis-based medicine, to 600 patients suffering from Multiple Sclerosis and a number of other conditions under a compassionate access programme.
Nov 8, 2005, 21:29
Latest Research
:
Psychiatry
:
Substance Abuse
:
Cannabis
Call for public health campaign on cannabis
The mental healthy charity Rethink on September 23 gave evidence to the Advisory Council on the Mis-use of Drugs, which is considering the classification of cannabis at the request of the Home Secretary and called for a long-term, properly funded public health campaign highlighting the mental health dangers of using cannabis.
Sep 28, 2005, 07:51
Latest Research
:
Psychiatry
:
Substance Abuse
:
Cannabis
Canada approved Cannabis extract Based Drug
Health Canada has approved Sativex� (Cannabis sativa L. extract) a new drug developed as adjunctive treatment for the symptomatic relief of neuropathic pain in adults with multiple sclerosis (MS).
Apr 21, 2005, 17:31
|
